14401-60-6

Basic information

• Product Name: 2-BROMO-5-METHYL-4-NITROPHENOL
• Synonyms: 2-BROMO-5-METHYL-4-NITROPHENOL
• CAS NO: 14401-60-6
• Molecular Formula: C₇H₆BrNO₃
• Molecular Weight: 232.03
• Mol File: 14401-60-6.mol
• Article Data: 5

Chemical Properties

• Melting Point: 127 °C
• Boiling Point: 310.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.755±0.06 g/cm3(Predicted)
• PKA: 5.63±0.24(Predicted)
• CAS DataBase Reference: 2-BROMO-5-METHYL-4-NITROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-5-METHYL-4-NITROPHENOL(14401-60-6)
• EPA Substance Registry System: 2-BROMO-5-METHYL-4-NITROPHENOL(14401-60-6)

Safety Data

• Hazardous Substances Data: 14401-60-6(Hazardous Substances Data)

Usage

General Description

2-Bromo-5-methyl-4-nitrophenol is a chemical compound with the molecular formula C7H6BrNO3. It is a yellow crystalline solid that is used in the production of fungicides and pharmaceuticals. It is known for its anti-bacterial and anti-fungal properties and is often used as an intermediate in the synthesis of various organic compounds. This chemical is also used as a reagent in organic synthesis and as a dye intermediate. It is important to handle this chemical with care due to its toxic and harmful properties.

Upstream product

• 2581-34-2 3-methyl-4-nitrophenol 
• 224185-19-7 3-bromo-4-fluoro-6-methylnitrobenzene 

Downstream Products

• 861084-04-0 5-bromo-4-methoxy-2-methylbenzenamine 
• 5456-94-0 2,4-dibromo-5-methylanisole 
• 861076-28-0 1-bromo-2-methoxy-4-methyl-5-nitrobenzene 

Relevant articles and documents

QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS

The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

Glucokinase Activators

Compounds are provided for use with glucokinase that comprise the formula: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders.